Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011-Reference-Cited by-同舟云学术

Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011

Published:2012-01 Issue:1 Volume:32 Page:1-2
ISSN:0197-3851
Container-title:Prenatal Diagnosis
language:en
Short-container-title:Prenat Diagn

Author:

Benn Peter¹,Borrell Antoni²,Cuckle Howard³,Dugoff Lorraine⁴,Gross Susan⁵,Johnson Jo-ann⁶,Maymon Ron⁷,Odibo Anthony⁸,Schielen Peter⁹,Spencer Kevin¹⁰,Wright Dave¹¹,Yaron Yuval¹²

Affiliation:

1. Department of Genetics and Developmental Biology; University of Connecticut Health Center; Farmington CT USA

2. Prenatal Diagnosis Unit, Institute of Gynecology, Obstetrics and Neonatology, Hospital Clinic, Maternitat Campus; University of Barcelona Medical School; Catalonia Spain

3. Department of Obstetrics and Gynecology; Columbia University Medical Center; New York NY USA

4. Department of Obstetrics and Gynecology; University of Pennsylvania; Philadelphia PA USA

5. Department of Obstetrics and Gynecology; Albert Einstein College of Medicine; New York NY USA

6. Department of Obstetrics and Gynecology; University of Calgary; Calgary AB Canada

7. Department of Obstetrics and Gynecology, Assaf Harofe Medical Center, Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

8. Department of Obstetrics and Gynecology; Washington University in St Louis; St Louis MO USA

9. Laboratory for Infectious Diseases and Perinatal Screening; National Institute for Public Health and the Environment (RIVM); Bilthoven The Netherlands

10. Prenatal Screening Unit, Clinical Biochemistry Department; Barking Havering and Redbridge University Hospital; King George Hospital; Goodmayes UK

11. Department of Mathematics and Statistics; University of Plymouth; Plymouth UK

12. Prenatal Diagnosis Unit, Genetic Institute; Sourasky Medical Center; Tel Aviv Israel

Publisher

Wiley

Subject

Genetics(clinical),Obstetrics and Gynaecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pd.2919/fullpdf

Reference5 articles.

1. Aneuploidy screening: a position statement on behalf of the Board of the International Society for Prenatal Diagnosis;Benn;Prenat Diagn,2011

2. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validation study;Chiu;Brit Med J,2011

3. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting;Ehrich;Am J Obstet Gynecol,2011

4. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study;Palomaki;Genet in Med,2011

5. Optimal detection of fetal chromosome abnormalities by massively parallel sequencing of cell-free fetal DNA from maternal blood;Sehnert;Clin Chem,2011

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between maternal serum biomarkers and the risk of fetal chromosome copy number variants: a single-center retrospective study;Archives of Gynecology and Obstetrics;2024-05-30

2. Understanding knowledge, perception, and willingness of non-invasive prenatal testing for fetal aneuploidy: a survey among Chinese high-risk pregnant women;Frontiers in Medicine;2023-10-16

3. A comprehensive performance analysis of sequence-based within-sample testing NIPT methods;PLOS ONE;2023-04-14

4. Focus on the frontier issue: progress in noninvasive prenatal screening for fetal trisomy from clinical perspectives;Critical Reviews in Clinical Laboratory Sciences;2023-01-16

5. Amniocentesis—When It Is Clear That It Is Not Clear;Journal of Clinical Medicine;2023-01-06